NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Lasertec Corporation (“Lasertec” or the “Company”) (OTC: LSRCF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Month: July 2024
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BridgeBio Pharma, Inc. (“BridgeBio” or the “Company”) (NASDAQ: BBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BridgeBio Pharma, Inc. (“BridgeBio” or the “Company”) (NASDAQ: BBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Toro Company (“Toro” or the “Company”) (NYSE: TTC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Toro Company (“Toro” or the “Company”) (NYSE: TTC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
PIKESVILLE, Md., July 24, 2024 /PRNewswire/ — Datumate (www.datumate.com), a leading provider of construction data analytics and photogrammetry solutions, and InTerra (https://interra5d.com/), a leader in GPS-enabled ground control points, are excited to announce a collaborative…
PIKESVILLE, Md., July 24, 2024 /PRNewswire/ — Datumate (www.datumate.com), a leading provider of construction data analytics and photogrammetry solutions, and InTerra (https://interra5d.com/), a leader in GPS-enabled ground control points, are excited to announce a collaborative…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmaceuticals, Inc. (“Zentalis” or the “Company”) (NASDAQ: ZNTL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of RH (“RH” or the “Company”) (NYSE: RH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RH…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ovid Therapeutics Inc. (“Ovid” or the “Company”) (NASDAQ: OVID). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…